Top Markets
#1 Official Trump Official Trump +38.83%
#2 Mubarak Mubarak +25.13%
#3 Movement Movement +20.14%
#4 Wrapped POL Wrapped POL +19.64%
#5 EXOD EXOD +18.93%
#6 Pearl Pearl +17.85%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.56%
#8 Melania Meme Melania Meme +17.02%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.39%
#10 Audiera Audiera +13.26%
Coin of the day
Official Trump Official Trump
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Hisse Senetlerindeki Sıralama #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Hisse Fiyatı
$3.78
Son senkronizasyon: 2026-08-21
Piyasa Değeri
$71.20M
Değişim (1 gün)
2.24%
Değişim (1 yıl)
-43.37%
Ülke
FR
Ticaret MaaT Pharma S.A. (MAAT)

Kategori

Healthcare
MaaT Pharma S.A. (MAAT) için kazanç
2026 itibarıyla kazanç TTM: 0
MaaT Pharma S.A. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
MaaT Pharma S.A. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH